Nephrocare Health Services Limited (NSE:NEPHROPLUS)
India · Delayed Price · Currency is INR 607.50
+22.05 (3.77%)
At close: May 22, 2026
NSE:NEPHROPLUS Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 768.4 | 670.96 | 351.33 | -117.89 | -219.75 |
Depreciation & Amortization | 906.67 | 719.18 | 540.19 | 465.16 | 389.03 |
Other Amortization | - | 5.51 | 8.66 | 3.63 | 3.69 |
Loss (Gain) From Sale of Assets | 12.76 | - | 0.65 | - | - |
Asset Writedown & Restructuring Costs | 0.89 | 4.26 | 12.28 | - | 27.68 |
Loss (Gain) From Sale of Investments | -26.97 | -7.55 | - | - | - |
Loss (Gain) on Equity Investments | 30.93 | - | - | - | - |
Stock-Based Compensation | 91.83 | 63.8 | 18.64 | 20.87 | 5.4 |
Provision & Write-off of Bad Debts | 237.78 | 88.57 | 114.89 | 66.68 | 83.28 |
Other Operating Activities | 359.91 | 250.47 | 6.18 | 207.48 | -5.45 |
Change in Accounts Receivable | -687.94 | -667.31 | -505.6 | -543.04 | -234.48 |
Change in Inventory | -54.93 | 0.67 | 9.7 | -108.38 | 16.99 |
Change in Accounts Payable | 328.07 | 398.71 | 183.68 | 135.45 | 11.48 |
Change in Other Net Operating Assets | 358.39 | -173.8 | -17.8 | -17.27 | 41.31 |
Operating Cash Flow | 2,326 | 1,353 | 722.8 | 112.69 | 119.18 |
Operating Cash Flow Growth | 71.84% | 87.25% | 541.41% | -5.45% | -63.39% |
Capital Expenditures | -1,189 | -997.75 | -773.49 | -715.69 | -429.7 |
Sale of Property, Plant & Equipment | 2.22 | - | - | - | - |
Cash Acquisitions | -503.99 | -125.41 | -281.37 | -64.17 | -626.82 |
Sale (Purchase) of Intangibles | -4.26 | -10.22 | -26.52 | -21.69 | -3.51 |
Investment in Securities | -1,646 | 47.27 | 459.66 | -46.03 | -642.23 |
Other Investing Activities | -763.27 | -164.62 | 115.12 | 65.52 | 27.38 |
Investing Cash Flow | -4,104 | -1,251 | -506.6 | -782.06 | -1,675 |
Short-Term Debt Issued | - | 81.05 | 13.73 | 620.78 | - |
Long-Term Debt Issued | - | - | 723.68 | 388.61 | 184.03 |
Total Debt Issued | - | 81.05 | 737.41 | 1,009 | 184.03 |
Short-Term Debt Repaid | -878.86 | - | - | - | -189.9 |
Long-Term Debt Repaid | -1,267 | -328.91 | -310.52 | -238.81 | -224.65 |
Total Debt Repaid | -2,146 | -328.91 | -310.52 | -238.81 | -414.55 |
Net Debt Issued (Repaid) | -2,146 | -247.86 | 426.89 | 770.58 | -230.53 |
Issuance of Common Stock | 3,902 | 979.65 | 5.58 | 23.63 | 1,811 |
Other Financing Activities | -184.78 | -188.08 | -165.08 | -194.55 | -111.98 |
Financing Cash Flow | 1,571 | 543.71 | 267.39 | 599.66 | 1,474 |
Foreign Exchange Rate Adjustments | 188.19 | 0.21 | -12.68 | 24.8 | - |
Net Cash Flow | -19.28 | 646.66 | 470.91 | -44.91 | -81.95 |
Free Cash Flow | 1,136 | 355.72 | -50.69 | -603 | -310.52 |
Free Cash Flow Growth | 219.47% | - | - | - | - |
Free Cash Flow Margin | 11.11% | 4.71% | -0.90% | -13.79% | -9.80% |
Free Cash Flow Per Share | 11.98 | 4.25 | -0.63 | -7.83 | -37.45 |
Cash Interest Paid | - | 188.1 | 165.08 | 161.13 | 96.66 |
Cash Income Tax Paid | - | 9.57 | 80.63 | -46.21 | 47.94 |
Levered Free Cash Flow | 958.62 | 110.99 | 20.41 | -1,417 | -279.76 |
Unlevered Free Cash Flow | 1,335 | 228.91 | 139.16 | -1,326 | -219.18 |
Change in Working Capital | -56.41 | -441.73 | -330.02 | -533.24 | -164.7 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.